{"changeSha256":"d97c090dbeba0d4cfe9272cdc226310d1cc98d57d37ac936471985d70c32bd5a","changedAt":"2026-07-27","changedFields":[{"after":"A multi-receptor metabolic candidate. This profile cites a ClinicalTrials.gov study record that was active, not recruiting.","before":"A multi-receptor metabolic candidate with active ClinicalTrials.gov records.","field":"Profile summary"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/retatrutide/versions/2/","version":2},"id":"profile:retatrutide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change.","peptideSlugs":["retatrutide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/retatrutide/versions/1/","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-nct06297603-v25","name":"ClinicalTrials.gov","sourceClass":"A","title":"Retatrutide in Participants With Type 2 Diabetes and Renal Impairment · record history version 25 · last update posted 2026-07-20","url":"https://clinicaltrials.gov/study/NCT06297603?a=25&tab=history","verifiedAt":"2026-07-22"}],"subject":{"slug":"retatrutide","type":"profile"}}